Inventor · Northbrook, IL, US

Steven W. Elmore

57Patents
20h-index
77Co-inventors
91Inventor score

Filing activity: Jun 5, 1995 → Oct 7, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US7390799B2 Apoptosis promoters Chemistry; Metallurgy 197 Active
US7767684B2 Apoptosis promoters Chemistry; Metallurgy 87 Active
US8563735B2 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Chemistry; Metallurgy 70 Active
US7642260B2 Apoptosis promoters Chemistry; Metallurgy 60 Active
US8546399B2 Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases Emerging Cross-Sectional Technologies 57 Active
US8586754B2 BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Chemistry; Metallurgy 55 Active
US7973161B2 Apoptosis promoters Chemistry; Metallurgy 50 Active
US8426422B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Chemistry; Metallurgy 47 Active
US7842681B2 Treatment of myeoproliferative diseases Human Necessities 47 Active
US8173811B2 Apoptosis promoters Chemistry; Metallurgy 42 Active
US8114893B2 Compounds and methods of use Chemistry; Metallurgy 42 Active
US8084607B2 Apoptosis promoters Chemistry; Metallurgy 37 Active
US8580794B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Chemistry; Metallurgy 35 Active
US8614318B2 Apoptosis promoters Chemistry; Metallurgy 35 Active
US7709467B2 Apoptosis promoters Chemistry; Metallurgy 35 Active
US6506766B1 Glucocortiocoid-selective antinflammatory agents Human Necessities 34 Expired
US8354404B2 Apoptosis promoters Chemistry; Metallurgy 33 Active
US8343967B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Chemistry; Metallurgy 32 Active
US8518970B2 Compounds and methods of use Chemistry; Metallurgy 28 Active
US8232273B2 Heterocyclic compounds and methods of use Chemistry; Metallurgy 26 Active
US8952157B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Emerging Cross-Sectional Technologies 19 Active
US9029404B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Chemistry; Metallurgy 16 Active
US9034875B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Chemistry; Metallurgy 16 Active
US5597823A Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists Chemistry; Metallurgy 16 Expired
US9174982B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Emerging Cross-Sectional Technologies 15 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.